teapawt
$
Curis, Inc.
@CurisInc
NASDAQ: CRIS
Lexington, MA
curis.com
Joined May 2016
Tweets
121
Following
50
Followers
334
Likes
12
34
Media
34
Media
Tweets
Tweets & Replies
Reposts
Media
Search
Curis, Inc. retweeted
Oncology Times
@OncologyTimes
9 Jun 2022
Findings suggest that CA-4948, a novel oral inhibitor of IRAK4 and FLT3, is a promising treatment for heavily pretreated
#AML
and high-risk
#myelodysplasticsyndrome
patients:
ow.ly/xOSv50JpXtV
#ASCO22
#HemOnc
#MDS
2
5
Load more